Fulltext

Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin

Saheb Sharif-Askari F 1 , Syed Sulaiman SA 1 , Saheb Sharif-Askari N 1 , Al Sayed Hussain A 2 , Railey MJ 3

Affiliations 

  • 1 School of Pharmacy, Universiti Sains Malaysia, Penang, Malaysia
  • 2 Pharmacy Department, Dubai Health Authority, Dubai, United Arab Emirates
  • 3 Nephrology Unit, Dubai Hospital, Dubai, United Arab Emirates
PLoS One, 2014;9(9):e106517.
PMID: 25181525 DOI: 10.1371/journal.pone.0106517

Abstract

Anticoagulation therapy is usually required in patients with chronic kidney disease (CKD) for treatment or prevention of thromboembolic diseases. However, this benefit could easily be offset by the risk of bleeding.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications